Global Drug-Eluting Bioabsorbable Stents Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Drug-Eluting Bioabsorbable Stents Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2059139
  • Published Date :
    June 1, 2022
  • Number of Pages :
    350.0

Product Description

The Drug-Eluting Bioabsorbable Stents market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario,  the market for Drug-Eluting Bioabsorbable Stents is projected to grow from US$ xx million in 2021, and is projected to reach xx by 2030, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Drug-Eluting Bioabsorbable Stents industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Drug-Eluting Bioabsorbable Stents by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Drug-Eluting Bioabsorbable Stents market are discussed.

The market is segmented by types: 
    Type I
    Type II

It can be also divided by applications:
    Coronary Artery Diseases
    Peripheral Artery Diseases

And this report covers the historical situation, present status and the future prospects of the global Drug-Eluting Bioabsorbable Stents market for 2021-2030. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    Medtronic
    B.Braun Melsungen
    Abbott Laboratories
    Boston Scientific Corporation
    Biosensors International
    Terumo Corporation.
    MicroPort Scientific Corporation
    Alvimedica
    Biotronik
    Elixir Medical Corporation
    Innovative Health Technologies

Report Includes:
- xx data tables and xx additional tables
- An overview of global Drug-Eluting Bioabsorbable Stents market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2030
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Drug-Eluting Bioabsorbable Stents market
- Profiles of major players in the industry, including     Medtronic,     B.Braun Melsungen,     Abbott Laboratories,     Boston Scientific Corporation,     Biosensors International.....

Research objectives
    To study and analyze the global Drug-Eluting Bioabsorbable Stents consumption (value & volume) by key regions/countries, product type and application, history data from 2018 to 2021, and Forecast to 2030.
    To understand the structure of Drug-Eluting Bioabsorbable Stents market by identifying its various subsegments.
    Focuses on the key global Drug-Eluting Bioabsorbable Stents manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Drug-Eluting Bioabsorbable Stents with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Drug-Eluting Bioabsorbable Stents submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global Drug-Eluting Bioabsorbable Stents Market Report 2022, Forecast to 2030

1 Scope of the Study
    1.1 Drug-Eluting Bioabsorbable Stents Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Drug-Eluting Bioabsorbable Stents Industry Overview
    2.1 Global Drug-Eluting Bioabsorbable Stents Market Size (Million USD) Comparison by Regions (2022-2030)
        2.1.1 Drug-Eluting Bioabsorbable Stents Global Import Market Analysis
        2.1.2 Drug-Eluting Bioabsorbable Stents Global Export Market Analysis
        2.1.3 Drug-Eluting Bioabsorbable Stents Global Main Region Market Analysis
    2.2 Market Analysis by Type
    2.3 Market Analysis by Application
        2.3.1 Coronary Artery Diseases
        2.3.2 Peripheral Artery Diseases
    2.4 Global Drug-Eluting Bioabsorbable Stents Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Drug-Eluting Bioabsorbable Stents Sales and Market Share by Manufacturer (2018-2021)
        2.4.2 Global Drug-Eluting Bioabsorbable Stents Revenue and Market Share by Manufacturer (2018-2021)
        2.4.3 Global Drug-Eluting Bioabsorbable Stents Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share
        2.4.5 Top 10 Drug-Eluting Bioabsorbable Stents Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market
        2.4.7 Key Manufacturers Drug-Eluting Bioabsorbable Stents Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Drug-Eluting Bioabsorbable Stents Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Drug-Eluting Bioabsorbable Stents Industry Impact
        2.7.1 How the Covid-19 is Affecting the Drug-Eluting Bioabsorbable Stents Industry
        2.7.2 Drug-Eluting Bioabsorbable Stents Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Drug-Eluting Bioabsorbable Stents Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 Drug-Eluting Bioabsorbable Stents Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Drug-Eluting Bioabsorbable Stents Market Size Categorized by Regions
    4.1 Global Drug-Eluting Bioabsorbable Stents Revenue, Sales and Market Share by Regions
        4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales and Market Share by Regions (2018-2021)
        4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue and Market Share by Regions (2018-2021)
    4.2 Europe Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    4.3 APAC Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    4.4 North America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    4.5 South America Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    4.6 Middle East & Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)

5 Europe Drug-Eluting Bioabsorbable Stents Market Size Categorized by Countries
    5.1 Europe Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Countries
        5.1.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Countries (2018-2021)
        5.1.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Countries (2018-2021)
        5.1.3 Germany Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        5.1.4 UK Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        5.1.5 France Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        5.1.6 Russia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        5.1.7 Italy Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        5.1.8 Spain Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    5.2 Europe Drug-Eluting Bioabsorbable Stents Revenue (Value) by Manufacturers (2018-2021)
    5.3 Europe Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Type (2018-2021)
        5.3.1 Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2018-2021)
        5.3.2 Europe Drug-Eluting Bioabsorbable Stents Revenue and Revenue Share by Type (2018-2021)
    5.4 Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2018-2021)

6 Asia-Pacific Drug-Eluting Bioabsorbable Stents Market Size Categorized by Countries
    6.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales by Countries (2018-2021)
        6.1.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue by Countries (2018-2021)
        6.1.3 China Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        6.1.4 Japan Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        6.1.5 Korea Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        6.1.6 India Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        6.1.7 Southeast Asia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        6.1.8 Australia Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    6.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales and Revenue (Value) by Manufacturers (2018-2021)
    6.3 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Type (2018-2021)
        6.3.1 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2018-2021)
        6.3.2 Asia-Pacific Drug-Eluting Bioabsorbable Stents Revenue and Revenue Share by Type (2018-2021)
    6.4 Asia-Pacific Drug-Eluting Bioabsorbable Stents Sales and Market Share by Application (2018-2021)

7 North America Drug-Eluting Bioabsorbable Stents Market Size Categorized by Countries
    7.1 North America Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Countries
        7.1.1 North America Drug-Eluting Bioabsorbable Stents Sales by Countries (2018-2021)
        7.1.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Countries (2018-2021)
        7.1.3 United States Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        7.1.4 Canada Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        7.1.5 Mexico Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    7.2 North America Drug-Eluting Bioabsorbable Stents Revenue (Value) by Manufacturers (2018-2021)
    7.3 North America Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Type (2018-2021)
        7.3.1 North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2018-2021)
        7.3.2 North America Drug-Eluting Bioabsorbable Stents Revenue and Revenue Share by Type (2018-2021)
    7.4 North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2018-2021)

8 South America Drug-Eluting Bioabsorbable Stents Market Size Categorized by Countries
    8.1 South America Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Countries
        8.1.1 South America Drug-Eluting Bioabsorbable Stents Sales by Countries (2018-2021)
        8.1.2 South America Drug-Eluting Bioabsorbable Stents Revenue by Countries (2018-2021)
        8.1.3 Brazil Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    8.2 South America Drug-Eluting Bioabsorbable Stents Revenue (Value) by Manufacturers (2018-2021)
    8.3 South America Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Type (2018-2021)
        8.3.1 South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2018-2021)
        8.3.2 South America Drug-Eluting Bioabsorbable Stents Revenue and Revenue Share by Type (2018-2021)
    8.4 South America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2018-2021)

9 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Categorized by Countries
    9.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Countries (2018-2021)
        9.1.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Countries (2018-2021)
        9.1.3 GCC Countries Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        9.1.4 Turkey Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        9.1.5 Egypt Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
        9.1.6 South Africa Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2018-2021)
    9.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue (Value) by Manufacturers (2018-2021)
    9.3 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2018-2021)
        9.3.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue and Revenue Share by Type (2018-2021)
    9.4 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2018-2021)

10 Global Drug-Eluting Bioabsorbable Stents Market Segment by Type
    10.1 Global Drug-Eluting Bioabsorbable Stents Revenue, Sales and Market Share by Type (2018-2021)
        10.1.1 Global Drug-Eluting Bioabsorbable Stents Sales and Market Share by Type (2018-2021)
        10.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue and Market Share by Type (2018-2021)

11 Global Drug-Eluting Bioabsorbable Stents Market Segment by Application
    11.1 Global Drug-Eluting Bioabsorbable StentsSales Market Share by Application (2018-2021)
    11.2 Coronary Artery Diseases Sales Growth Rate (2018-2021)
    11.3 Peripheral Artery Diseases Sales Growth Rate (2018-2021)

12 Market Forecast for Drug-Eluting Bioabsorbable Stents
    12.1 Global Drug-Eluting Bioabsorbable Stents Revenue, Sales and Growth Rate (2022-2030)
    12.2 Drug-Eluting Bioabsorbable Stents Market Forecast by Regions (2022-2030)
        12.2.1 Europe Drug-Eluting Bioabsorbable Stents Market Forecast (2022-2030)
        12.2.2 APAC Drug-Eluting Bioabsorbable Stents Market Forecast (2022-2030)
        12.2.3 North America Drug-Eluting Bioabsorbable Stents Market Forecast (2022-2030)
        12.2.4 South America Drug-Eluting Bioabsorbable Stents Market Forecast (2022-2030)
        12.2.5 Middle East & Africa Drug-Eluting Bioabsorbable Stents Market Forecast (2022-2030)
    12.3 Drug-Eluting Bioabsorbable Stents Market Forecast by Type (2022-2030)
        12.3.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2022-2030)
        12.3.2 Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Type (2022-2030)
    12.4 Drug-Eluting Bioabsorbable Stents Market Forecast by Application (2022-2030)
        12.4.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2022-2030)
        12.4.2 Global Drug-Eluting Bioabsorbable Stents Market Share Forecast by Application (2022-2030)

13 Analysis of Drug-Eluting Bioabsorbable Stents Industry Key Manufacturers
    13.1 Medtronic
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.1.4 Main Business Overview
        13.1.5 Medtronic News
    13.2 B.Braun Melsungen
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.2.4 Main Business Overview
        13.2.5 B.Braun Melsungen News
    13.3 Abbott Laboratories
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.3.4 Main Business Overview
        13.3.5 Abbott Laboratories News
    13.4 Boston Scientific Corporation
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.4.4 Main Business Overview
        13.4.5 Boston Scientific Corporation News
    13.5 Biosensors International
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.5.4 Main Business Overview
        13.5.5 Biosensors International News
    13.6 Terumo Corporation.
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.6.4 Main Business Overview
        13.6.5 Terumo Corporation. News
    13.7 MicroPort Scientific Corporation
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.7.4 Main Business Overview
        13.7.5 MicroPort Scientific Corporation News
    13.8 Alvimedica
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.8.4 Main Business Overview
        13.8.5 Alvimedica News
    13.9 Biotronik
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.9.4 Main Business Overview
        13.9.5 Biotronik News
    13.10 Elixir Medical Corporation
        13.10.1 Company Details
        13.10.2 Product Information
        13.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.10.4 Main Business Overview
        13.10.5 Elixir Medical Corporation News
    13.11 Innovative Health Technologies
        13.11.1 Company Details
        13.11.2 Product Information
        13.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.11.4 Main Business Overview
        13.11.5 Innovative Health Technologies News

14 Research Findings and Conclusion

15 Appendix

Search results for Medical Devices Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Agriculture

Construction

Top Rated Products